NOCDURNA

Antares Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 19, 2023
Approval ID: cf51914a-55df-4b4a-8ea8-c7af257c1d59
Products: 2 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NOCDURNA safely and effectively. See full prescribing information for NOCDURNA. NOCDURNA (desmopressin acetate) sublingual tablets Initial U.S. Approval: 1978

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.